ÌÚ²©»á¹ÙÍø

ÌÚ²©»á¹ÙÍø¡¤×¨ÒµÐ§ÀÍ,³ÏÐÅΪ±¾
¼ìË÷ÆÊÎö

PRODUCT SERVICE

¼ìË÷ÆÊÎö
¹¤¾ß

PQD

Pharma & Biotech ÖÆÒ©ÓëÉúÎï¼¼Êõ

ProQuest Dialogƽ̨Ìṩ¸»ºñ¶àÑùµÄÖÆÒ©ÓëÉúÎï¼¼ÊõÊý¾Ý¿â¼ìË÷ £¬°üÀ¨ADIS R&DInsightÒ©ÎïÆ·ÖÖÊý¾Ý¿âÔÚÄÚµÄÁè¼Ý16¸öÒ½Ò©ÉúÎï¼¼ÊõÏà¹ØµÄÊý¾Ý¿â¡£¿ÉÒԱ㵱ÖÆÒ©ÆóÒµ¡¢¿ÆÑÐÔºËùÁ˽âÒ©ÎïÑз¢½øÕ¹ £¬Ò©Àí¶¾Àí £¬ÁÙ´²ÊÔÑéÇé¿ö £¬ÉÏÊмÁÐÍ £¬ÏúÊÛµÈÐÅÏ¢¡£

ÌÚ²©»á¹ÙÍø¡¤×¨ÒµÐ§ÀÍ,³ÏÐÅΪ±¾

Êý¾Ý¿âÁÐ±í£º

±àºÅ      Êý¾Ý¿âÃû³Æ

1      ADIS R&D Insight

2      Allied & Complementary Medicine

3      Analytical Abstracts

4      British Nursing Index

5      Chemical Engineering and BiotechnologyAbstracts

6      CSA Life Sciences Abstracts

7      Current Contents

8      Espicom Pharmceutical & Medcine Device News

9      FDAnews

10      Gale Group Health&wellness/Gale HealthPerodicals Database

11      Lancert Titles

12      M2 Pharma

13      Material Safety Data Sheets

14      Medline

15      New England Journal of Medcine

16      Toxfile

ÁªÏµÌÚ²©»á¹ÙÍø

    • ÌÚ²©»á¹ÙÍø
    • µØµã£º¹ãÖÝÊÐÔ½ÐãÇøÏÈÁÒÖз80ºÅ»ã»ªÉÌó´óÏÃ620ÊÒ
    • µç»°£º020-38303455
    • ´«Õ棺020-38303532
    • Óʱࣺ510070
    • ÓÊÏ䣺info@ourchem.com
    • ¹ãÖÝÌÚ²©»á¹ÙÍø֪ʶ²úȨЧÀÍÓÐÏÞ¹«Ë¾
    • µØµã£º¹ãÖÝÊпª·¢Çø¿Æѧ³Ç¿Æѧ´óµÀ241ºÅ×ܲ¿¾­¼ÃÇøA4¶°10²ã
    • Óʱࣺ510520
    • ±±¾©ÌÚ²©»á¹ÙÍø֪ʶ²úȨЧÀÍÓÐÏÞ¹«Ë¾
    • µØµã£º±±¾©Êк£µíÄÏ·¼×21ºÅÖйشå֪ʶ²úȨ´óÏÃB×ù5106ÊÒ
    • µç»°£º010-82350736
    • Óʱࣺ100083
    • ÓÊÏ䣺bjadm@ourchem.com
    • ÄϾ©ÌÚ²©»á¹ÙÍø֪ʶ²úȨЧÀÍÓÐÏÞ¹«Ë¾
    • µØµã£ºÄϾ©Êн­ÄþÇøÓ­´ä·7ºÅǧÈË´óÏÃ3010
    • µç»°£º025-83235567
    • ÉϺ£ÌÚ²©»á¹ÙÍø֪ʶ²úȨЧÀÍÓÐÏÞ¹«Ë¾
    • µØµã£ºÉϺ£ÊÐÐì»ãÇøÌïÁÖ·388ºÅ1´±1118ÊÒ
    • µç»°£º021-64473525
    • Óʱࣺ200233
    • ÓÊÏ䣺shinfo@ourchem.com
    • ¹ãÎ÷ÌÚ²©»á¹ÙÍø֪ʶ²úȨЧÀÍÓÐÏÞ¹«Ë¾
    • µØµã£ºÄÏÄþÊÐÐÂÖñ·20ºÅ¹ãÎ÷¿ÆѧÔ˶¯ÖÐÐÄ2ºÅÂ¥301ÊÒ
    • µç»°£º0771-5383979
    • Óʱࣺ530000
    • Ö£ÖÝÌÚ²©»á¹ÙÍø֪ʶ²úȨЧÀÍÓÐÏÞ¹«Ë¾
    • µØµã£ºÖ£ÖÝÊнðË®Çø¹ú»ù·½ÖµÀ¹ú¼Ò֪ʶ²úȨ´´Ò⹤ҵÊÔµãÔ°Çø 1403ÊÒ
    • Óʱࣺ450000
    • ËÕÖÝÌÚ²©»á¹ÙÍø֪ʶ²úȨЧÀÍÓÐÏÞ¹«Ë¾
    • µØµã£ºËÕÖÝÊиßÐÂÇø¿Æ¼¼³Çѧɭ·9ºÅ701ÊÒ
    • Óʱࣺ215163
    • µç»°£º13928814827
    • ÓÊÏ䣺jane@ourchem.com
    • Î÷°²ÌÚ²©»á¹ÙÍø֪ʶ²úȨЧÀÍÓÐÏÞ¹«Ë¾
    • µØµã£ºÎ÷°²ÊиßÐÂÇøÌÆÑÓ·25ºÅÒøºÓ¿Æ¼¼´óÏÃ4²ãB501
    • Óʱࣺ710000
    • »ÝÖÝÌÚ²©»á¹ÙÍø֪ʶ²úȨЧÀÍÓÐÏÞ¹«Ë¾
    • µØµã£º»ÝÖÝÊж«½­¸ßÐÂÇø¶«Ð´óµÀ¿Æ¼¼Ô°A2¶°¶þÂ¥214ÊÒ
    • Óʱࣺ516002
    • ³É¶¼Ö®¿­ÖªÊ¶²úȨЧÀÍÓÐÏÞ¹«Ë¾
    • µØµã£º³É¶¼»á½ðÅ£ÇøÏ£¶÷¹ú¼Ê702ÊÒ
    • Óʱࣺ610000
    • ÎÞÎýÌÚ²©»á¹ÙÍø֪ʶ²úȨЧÀÍÓÐÏÞ¹«Ë¾
    • µØµã£ºÎÞÎýÊбõºþÇø½¨ÖþÎ÷·583ºÅ3Â¥
    • ¶«Ý¸ÌÚ²©»á¹ÙÍø֪ʶ²úȨЧÀÍÓÐÏÞ¹«Ë¾
    • µØµã£º¹ã¶«Ê¡¶«Ý¸ÊÐËÉɽºþÔ°ÇøºìÃÞ·6ºÅ11¶°201ÊÒ
    • ÖÐɽÌÚ²©»á¹ÙÍø֪ʶ²úȨЧÀÍÓÐÏÞ¹«Ë¾
    • µØµã£ºÖÐɽÊлð¾æ¿ª·¢Çø»áÕ¹¶«Â·16ºÅÊýÂë´óÏÃ309-10
    • ÂåÑôÌÚ²©»á¹ÙÍø֪ʶ²úȨЧÀÍÓÐÏÞ¹«Ë¾
    • µØµã£ºÂåÑôÊÐÒÁ±õÇøÐÂԴ·27ºÅÉÌ»á´óÏÃB-2505¡¢B-2507ÊÒ
ÌÚ²©»á¹ÙÍø¡¤×¨ÒµÐ§ÀÍ,³ÏÐÅΪ±¾

Ãâ·ÑÌåÑé֪ʶ²úȨרҵЧÀÍ

? µÚһʱ¼ä»ñÈ¡ÐÐÒµ¶¯Ì¬
? Ãâ·ÑÐÐÒµ±¨¸æÏÂÔØ
? ÌåÑéרÀû¼ìË÷ЧÀÍ
? ÔÚÏß¿Í·þ´ðÒÉ

ÊÖ»úɨÂë¼´Ïí

2000-2030 ÌÚ²©»á¹ÙÍø °æȨËùÓÐ ÔÁICP±¸13056780ºÅ ÌÚ²©»á¹ÙÍø¡¤×¨ÒµÐ§ÀÍ,³ÏÐÅΪ±¾

ÌÚ²©»á¹ÙÍø¡¤×¨ÒµÐ§ÀÍ,³ÏÐÅΪ±¾
ɨÂë¹Ø×¢ÃñÖÚºÅ
ÍøÕ¾µØͼ
ÓÑÇéÁ´½Ó£ºAGÕæÈ˹ú¼Ê  K8¿­·¢Ò»´¥¼´·¢  ÇòËÙÌåÓý  BevictorΤµÂ  yl23455ÓÀÀû  ÍþÁ®Ï£¶û  AGÆì½¢Ìü  qyÇòÓÑ»áÌåÓý  8868ÌåÓý¹ÙÍø  ±ØÒ»ÌåÓý  ÀûÀ´¼¯ÍÅ  ng28ÄϹ¬  UG»·Çò¹ÙÍø  BsportsÌåÓý  ½ñÄê»á